Constructing polycompetitor cDNAs for quantitative PCR.

Analysis of mRNA levels using reverse transcription coupled with the polymerase chain reaction provides a powerful tool for studying cytokine regulation in cellular immunology. We report a novel method for cloning competitor cDNAs that is rapid, efficient and inexpensive. By linking multiple competitor cDNAs in tandem, polycompetitor constructs can be created that allow the use of a single reagent for individual PCR assays. Assays can be performed on minute samples of cell culture or tissue and can be reliably quantitated after routine gel electrophoresis without the use of densitometry or labeled nucleotides. The utility of this technique lies in the ability to produce a relatively inexpensive customized reagent that is simple to use and that allows for sensitive determinations of gene expression in a rapid and convenient manner. This method should allow investigators in many areas of biology to easily quantitate a broad range of important regulatory molecules.

[1]  S. Carding,et al.  A polymerase chain reaction assay for the detection and quantitation of cytokine gene expression in small numbers of cells. , 1992, Journal of immunological methods.

[2]  T. Taniguchi,et al.  Unique structure of murine interleukin-2 as deduced from cloned cDNAs , 1985, Nature.

[3]  T. Mosmann,et al.  Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. , 1990, Science.

[4]  D. Goeddel,et al.  Cloning and expression of murine immune interferon cDNA. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[5]  M. Suthanthiran,et al.  Differential regulation of transforming growth factor beta and interleukin 2 genes in human T cells: demonstration by usage of novel competitor DNA constructs in the quantitative polymerase chain reaction , 1991, The Journal of experimental medicine.

[6]  B. Beutler,et al.  Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[7]  P. Familletti,et al.  Cloning and expression of murine IL-12. , 1992, Journal of immunology.

[8]  T. Honjo,et al.  Cloning of complementary DNA encoding T-cell replacing factor and identity with B-cell growth factor II , 1986, Nature.

[9]  V. Chapman,et al.  Altered turnover of allelic variants of hypoxanthine phosphoribosyltransferase is associated with N-terminal amino acid sequence variation. , 1988, The Journal of biological chemistry.

[10]  E. Chen,et al.  The murine transforming growth factor-beta precursor. , 1986, The Journal of biological chemistry.

[11]  R. Locksley,et al.  Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets , 1989, The Journal of experimental medicine.

[12]  Z. Wang,et al.  Competitor mRNA fragments for quantitation of cytokine specific transcripts in cell lysates. , 1993, Molecular immunology.

[13]  A. Sher,et al.  Protection against Leishmania major in BALB/c mice by adoptive transfer of a T cell clone recognizing a low molecular weight antigen released by promastigotes. , 1990, Journal of immunology.

[14]  Terry D. Lee,et al.  Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. , 1992, Science.

[15]  H. Blöcker,et al.  Analysis of cytokine mRNA levels in interleukin‐4‐transgenic mice by quantitative polymerase chain reaction , 1992, European journal of immunology.

[16]  R. Coffman,et al.  Isolation and characterization of a mouse interleukin cDNA clone that expresses B-cell stimulatory factor 1 activities and T-cell- and mast-cell-stimulating activities. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Michael V. Doyle,et al.  Quantitation of mRNA by the Polymerase Chain Reaction , 1989 .

[18]  S. Perrin,et al.  8 – COMPETITIVE PCR FOR QUANTITATION OF mRNA , 1990 .

[19]  C. Janeway,et al.  Both a monoclonal antibody and antisera specific for determinants unique to individual cloned helper T cell lines can substitute for antigen and antigen-presenting cells in the activation of T cells , 1983, The Journal of experimental medicine.

[20]  F. Collins,et al.  Construction of T-vectors, a rapid and general system for direct cloning of unmodified PCR products. , 1991, Nucleic acids research.